Is a Positive NECPAL in ICU Patients Associated With Higher Mortality
ConditionAcute Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age75+
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
About this trial
The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men and women aged 75 years or older.
Admission to the ICU of the study center.
Legal capacity to provide informed consent.
Signed informed consent for study inclusion, either by the participant or their legal representative.
Disqualifiers
None
Trial population
Patients aged 75 years or older who are admitted to an ICU
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
NECPAL positive
Other interventionThis group has a positive result for NECPAL scale
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Mortality
Patients who dye at 90-day from ICU admission
Time frame
From baseline to 90-daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov